The application of AI and machine learning in establishing a treatment’s value proposition is still a relatively new concept in pharma. Katya Svoboda, Taneesha Chawla, and Tanvi Ahuja, authors of the ICON whitepaper, The Impact of Artificial Intelligence on Outcomes Based Contracting discuss the challenges and opportunities in the October 2019 issue of PharmExec.
View Article